Bronx Times - April 2, 2021
Allison Ludwig, M.D., talks about Einstein's Match Day success in the face of challenges from the COVID-19 pandemic, and fourth-year student Veronica Ortiz recounts her medical school journey and successful match to a pediatrics residency. Dr. Ludwig is associate dean for student affairs, associate professor of medicine at Einstein, and a hospitalist at Jacobi.
Dr. Ludwig's Profile
Science News - March 28, 2021
Richard Lipton, M.D., discusses the use of a newer class of migraine drugs known as gepants, which target a neurotransmitter implicated in migraine. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein, and director of the Montefiore Headache Center.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
Discover Magazine - March 27, 2021
Dawn Buse, Ph.D., describes the triggers and phases of migraines and explains that a variety of treatments are available to people who suffer from the debilitating headaches. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology.
Dr. Buse's Profile
The Scientist - March 24, 2021
Stephanie Rudolph, Ph.D., discusses a study that confirms the relationship between the size of synapses in the brain and their strength, which has implications for memory and learning. Dr. Rudolph is assistant professor in the Dominick P. Purpura Department of Neuroscience and of psychiatry and behavioral sciences.
Dr. Rudolph's Profile
US News & World Report - March 18, 2021
Sofiya Milman, M.D., M.S., comments on recent research that confirmed people age at different rates. She notes that both genes and factors such as poverty, stress, diet, and exercise influence how fast or slowly a person's body systems age and decline. Dr. Milman is associate professor of medicine and of genetics and is director of human longevity studies at the Institute for Aging Research.
Dr. Milman's ProfileMore coverage on Dr. Milman
BronxNet - March 16, 2021
Edward Chu, M.D., discusses the importance of regular colorectal cancer screening for those over 45, as well as the disease's risk factors and prevalence. Dr. Chu is director of the Albert Einstein Cancer Center, vice president for cancer medicine at Montefiore Medicine, professor of medicine and of molecular pharmacology and is the Carol and Roger Einiger Professor of Cancer Medicine at Einstein.
Dr. Chu's Profile
The Wall Street Journal - March 11, 2021
David Sharp, Ph.D., discusses a drug, discovered in his lab and licensed to a company he co-founded, that in preclinical studies helped regenerate nerve cells damaged in spinal-cord injuries. Dr. Sharp is professor of physiology & biophysics, of ophthalmology and visual sciences, and in the Dominick P. Purpura Department of Neuroscience.
Dr. Sharp's Profile
National Institute on Aging News - March 11, 2021
Research led by Ana Maria Cuervo, M.D., Ph.D., has found that improving autophagy, the process by which cells recycle and remove waste, in blood stem cells can reverse age-related declines in the immune systems of mice—findings that may have relevance for human health. Dr. Cuervo is professor of developmental and molecular biology, of anatomy and structural biology, and of medicine, co-director of the Institute for Aging Research, and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein.
Dr. Cuervo's ProfileMore coverage on Dr. Cuervo
Newsweek - March 8, 2021
Susan Band Horwitz, Ph.D., is featured as one of seven women who changed science. Dr. Horwitz is recognized for her discovery of the mechanism for action for the blockbuster cancer chemotherapeutic drug Taxol. Dr. Horwitz is distinguished professor emerita of molecular pharmacology and the Rose C. Falkenstein Professor of Cancer Research.
Dr. Horwitz's ProfileMore coverage on Dr. Horwitz
The Washington Post - March 6, 2021
Nir Barzilai, M.D., discusses his proposed clinical trial to test whether the diabetes drug metformin can delay age-related diseases such as cancer and Alzheimer's disease. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Infection Control Today - March 2, 2021
Priya Nori, M.D., talks about the re-emergence of multi-drug resistant bacteria and fungi in the wake of the COVID-19 pandemic and the important role infectious disease physicians can play in preventing outbreaks and ensuring patient safety. Dr. Nori is associate professor of medicine and of orthopaedics at Einstein and medical director of the antimicrobial stewardship program at Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
ABC 7 NY - February 3, 2021
Montefiore and Einstein will receive $13 million from New York City as part of its investment in new biotech centers. The Einstein-Montefiore Biotechnology Accelerated Research Center (EMBARC) will establish a biomanufacturing operation focused on cell, gene, and antibody therapy production and will provide scientific facilities to early-stage and established companies.
Additional Coverage includes AMNY, New York Business Journal, Connect New York, Patch.com, Yahoo News, and WPIX11
The Scientist - January 8, 2021
Kartik Chandran, Ph.D., talks about the future of COVID-19 research, including the development of treatments and vaccines to treat and prevent the novel coronavirus as it mutates over time. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
The New York Times - January 6, 2021
Liise-anne Pirofski, M.D., discusses a small Argentinian clinical trial that found convalescent plasma was effective in reducing the risk of severe COVID-19 in older patients if they received the treatment within three days of showing symptoms. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
The New York Times - December 28, 2020
Jonathan Alpert, M.D., Ph.D., and Vilma Gabbay, M.D., discuss their published case report on two patients who developed psychosis for the first time after recovering from COVID-19. Dr. Alpert is chair of psychiatry and behavioral sciences at Einstein and Montefiore and Dr. Gabbay is co-director of the Psychiatry Research Institute at Montefiore Einstein.
Dr. Alpert's Profile
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.